Bilcare Global Clinical Supplies (Europe) Ltd. Forms Corporate Advisory Board; Inducts Former Pfizer Inc. (PFE) President and the Executive Director of Waterloo Institute of Nanotechnology as Members
4/30/2008 10:36:40 AM
PHOENIXVILLE, PA--(Marketwire - April 30, 2008) - Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial services, has formed its first corporate Advisory Board. Bilcare Limited's Chairman and Managing Director Mohan Bhandari announced former Pfizer President John LaMattina, Ph.D., and Waterloo Institute of Nanotechnology Executive Director Arthur Carty, Ph.D., D.Sc., as the board's inaugural members. Dr. LaMattina will serve as its Chairman. The advisory board was created to provide the Bilcare GCS Senior Management Team with independent scientific industry expertise and insight to assist in the accomplishment of scientific and business objectives in support of the company's global mission. "The formation of our corporate Advisory Board is another major milestone in our mission to make Bilcare GCS the global leader in the clinical trial supplies arena," said Bhandari. "The addition of these accomplished members will prove to be a tremendous asset to research and innovation initiatives of our company."
comments powered by